Biotage AB Nomination Committee

Biotage AB Nomination Committee

A Nomination Committee consisting of shareholder representatives and the
Chairman of the Board of Directors has been formed for Biotage AB. The
Nomination Committee shall, before the Annual General Meeting 2010, prepare
proposals for the election of Chairman and other members of the Board of
Directors, the election of Chairman of the Annual General Meeting, the
determination of fees and matters pertaining thereto.

The members of the Nomination Committee are: 

Björn Odlander, HealthCap 

Karl Swartling, Investor Growth Capital

Anders Walldow, Brohuvudet AB and direct holding

Ove Mattsson, Chairman of the Board


Shareholders wishing to submit a proposal for members of the Board of Directors
may do so sending e-mail to the Chairman of the Board of Directors of Biotage AB
at info@eu.biotage.com.


Contact:
Torben Jörgensen, President and CEO
Tel: +46 707 49 05 84, torben.jorgensen@biotage.com


This is information that Biotage AB (publ) is required to disclose pursuant to
the Swedish Securities Markets Act. The information was provided for public
release on 19 October 2009 at 12.00 CET

About Biotage 
Biotage offers solutions, knowledge and experience in the areas of analytical
and medicinal chemistry. The customers include the world's top pharma and
biotech companies, as well as leading academic institutes. The company is
headquartered in Uppsala, Sweden, and has offices in the United States, United
Kingdom and Japan. Biotage has 270 employees and had sales of SEK 385,3m in
2008. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange. Website:
www.biotage.com